Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
Scotiabank Sticks to Its Buy Rating for Pacific Biosciences (PACB)
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
UBS Trims Pacific Biosciences of California Price Target to $12 From $12.50, Maintains Buy Rating
UBS Lifts Price Target on Pacific Biosciences of California to $12.50 From $10, Keeps Buy Rating
Stephens & Co. Initiates Coverage On Pacific Biosciences With Overweight Rating, Announces Price Target of $11
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
UBS Upgrades Pacific Biosciences to Buy, Lowers Price Target to $10
Pacific Biosciences Analyst Ratings
Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $8
Pacific Biosciences Analyst Ratings
Cantor Fitzgerald Upgrades Pacific Biosciences to Overweight, Lowers Price Target to $11